by In2Pharma | Oct 25, 2021 | News
Luxembourg The Luxembourg national competent authority Division de la Pharmacie et des Médicaments de la Direction de la Santé has published 2 new documents. Instructions for marketing authorization holders for preparation and submission of additional risk...
by In2Pharma | May 4, 2021 | News
The Netherlands The Dutch Medicines Evaluation Board (MEB) published an update of the policy document (MEB 44) regarding Direct Healthcare Professional Communications (DHPCs). This policy presents a framework for the way in which the MEB deals with DHPCs and the...
by In2Pharma | Jun 11, 2020 | News
The Netherlands The Medicines Evaluation Board (MEB) has amended its policy on Direct Healthcare Professional Communications (DHPCs) for medicinal products for human use. The update includes the following: “The marketing authorisation holder must attach one (or more)...
